US EditionAssetmark Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. $REGN
Assetmark Inc. sold 106,802 Regeneron shares in Q3, retaining $11.7 million in stock as part of wider institutional portfolio shifts, SEC filing shows.
2 Articles
2 Articles
Assetmark Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. $REGN
Assetmark Inc. lowered its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 83.7% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 20,819 shares of the biopharmaceutical company’s stock after selling 106,802 shares during the quarter. Assetmark Inc.’s holdings in Regeneron Pharmaceuticals were worth $11,706,000 as of its most recent SEC filing. Other institutional inves…
Regeneron Pharmaceuticals, Inc. $REGN Stake Reduced by CENTRAL TRUST Co
CENTRAL TRUST Co trimmed its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 56.5% in the third quarter, Holdings Channel.com reports. The fund owned 519 shares of the biopharmaceutical company’s stock after selling 673 shares during the period. CENTRAL TRUST Co’s holdings in Regeneron Pharmaceuticals were worth $292,000 at the end of the […]
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
